Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fear of movement may hinder recovery in LVAD patients

NCT ID NCT07394621

Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study looks at whether fear of movement (kinesiophobia) affects how well heart failure patients with a Left Ventricular Assist Device (LVAD) can move and function. Researchers will measure fear levels and physical capacity before and one month after patients leave the hospital. Participants will also get simple activity recommendations to see if reducing fear helps them recover better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could show that reducing fear of movement helps heart failure patients with LVADs recover better, pointing toward better rehabilitation programs.
What could go wrong
This is a small, early observational study with only 37 participants, so results may not apply to everyone. It measures changes over one month, which is a short time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Jan 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being a heart transplant candidate and having undergone LVAD implantation, * Having a left ventricular ejection fraction (LVEF) \<30%, * Not having developed any surgical or medical complications in the early period after implantation, * Being referred to the study by a cardiologist at the time of discharge, * Being able to read and write and volunteering to participate in the study. Exclusion Criteria: * Those with evidence of active infection following implantation, * Psychiatric problems developing after LVAD implantation that interfere with cognitive adaptation, * Musculoskeletal problems developing after LVAD implantation, * Cases experiencing acute cardiac problems requiring hospitalization during follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure Kinesiophobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kinesiophobia (fear of movement)

Contacts and locations

Locations

  • Marmara University Faculty of Health Sciences

    Istanbul, 34854, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.